Efg Asset Management (North America) Corp. Avidity Biosciences, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $585 Million
- Q3 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 61,305 shares of RNA stock, worth $1.89 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
61,305
Previous 29,992
104.4%
Holding current value
$1.89 Million
Previous $1.23 Million
129.8%
% of portfolio
0.48%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
254Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$328 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$285 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$266 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$251 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$217 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.61B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...